Atlas Trials

Refractory Urothelial Carcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Urothelial Carcinoma

RecordFirmDate
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors (NCT05733000)Northwestern University2023-03-08
Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer (NCT04579224)National Cancer Institute (NCI)2021-06-28
Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma (NCT04856189)Mamta Parikh2021-04-08

Track Refractory Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.